NA Proactive news snapshot: CleanSpark, WeedMD, Q BioMed, Great Panther Mining UPDATE ...

CleanSpark Inc (NASDAQ:CLSK) has received a $1.6 million order to provide its intelligent automatic transfer switch (ATS) switchgear technology to shopping centers. ATS is a mechanism that ensures uninterrupted power by automatically transferring power supply from a primary source to a backup source when it senses a failure or outage in the primary source. The units are expected to ship over the next two fiscal quarters.  WeedMD Inc (CVE:WMD) (OTCMKTS:WDDMF), the cannabis-focused producer, said it has appointed director Angelo Tsebelis as its new chief executive officer (CEO) after Keith Merker chose to step down. Tsebelis has nearly two decades' experience in the pharmaceutical, healthcare and cannabis industries and he has been responsible for setting strategic commercialization and product development initiatives for both WeedMD and newly acquired subsidiary Starseed Medical. His CV also includes commercial leadership roles at pharma giant GlaxoSmithKline PLC (LON:GSK), Bell Canada and Harrison Associates. Q BioMed Inc (OTCMKTS:QBIO) announced Tuesday that its research and technology partner, Mannin Research Inc, is developing new therapeutics to treat a variety of vascular diseases, including the strain of the deadly coronavirus from Wuhan in China. In a statement, Q BioMed said Mannin is developing a new class of drugs to treat various vascular diseases. Its lead research platform targets the activation of the Angiopoietin-Tie2 signaling pathway. In a nutshell, Angiopoietin-1 promotes sprouting and survival of endothelial cells through the activation of different signaling pathways. It is developing a new class of drugs that may boost survival rates by reducing endothelial cell dysfunction. Great Panther Mining Limited (TSE:GPR) (NYSEAMERICAN:GPL) announced Tuesday that it received US$11.25 million as part of a gold doré prepayment agreement with Samsung C&T UK Ltd. The Vancouver-based miner also set a limited gold floor price of US$1,500 through the purchase of financial put options to protect its margins from any price fluctuations. The firm purchased put options on 45,000 gold ounces that mature from March through to the end of June 2020 at an average cost of US$9.33 per gold ounce, ensuring a minimum sale price of US$1,500 for the majority of gold production from its Tucano mine in Brazil. Allot Ltd (NASDAQ:ALLT) (TASE:ALLT), the smart network intelligence solutions company, reported fourth-quarter earnings and revenue early Tuesday that handily beat Wall Street expectations, boosted by its security offerings, which drew several new operators. For the quarter ended December 2019, Allot posted a non-GAAP net loss of $1.7 million, or $0.05 per share, on revenue of $30.6 million, an increase of 14% compared to $26.9 million in the fourth quarter of 2018. The consensus estimate was a loss of $0.08 per share. Investors responded well, sending shares nearly 12.9% higher to $10.96 before the opening bell. It expects 2020 revenue of $135 to $140 million and to reach profitability in the last quarter of the year. NexTech AR Solutions Corp (OTCMKTS:NEXCF) (CSE:NTAR) announced the launch Tuesday of its 3D augmented reality (AR) advertising network. The AR ads can show any product — a fleece jacket, a vacuum or even a plate of ribs — in full 3D for users to drag around and view from every angle. EuroLife Brands Inc (CSE:EURO) (OTCMKTS:EURPF), the cannabis education group, is shaking things up by striking a deal with Aphria Inc (TSX:APHA) (NYSE:APHA), the Ontario-based cannabis behemoth, to relaunch its budtender education portal, a go-to site for hundreds of cannabis retailers. Explorex Resources Inc (CSE:EX) (OTCMKTS:EXPXF) has set out the terms, in which it will spin out its exploration assets, as part of a series of deals leading to a reverse takeover of Raffles Financial Private Ltd.  As reported on December 23, the move marks a fundamental shift in direction for the resource group as it becomes a financial services group. Explorex's current exploration assets, including in Finland and Canada, along with C$500,000, will be spun out, with shareholders to receive one share of the 'Spinco' in exchange for two Explorex shares. Spinco then intends to seek a listing on the Canadian Securities Exchange (CSE). Weekend Unlimited Industries Inc (CSE:POT) (OTCMKTS:WKULF) said Tuesday that it is “excited” to be deploying True North Cannabis's specialized product upgrade process for the 2020 organic biomass grown on its 600-acre Northern Lights Organics hemp farm in British Columbia. In a statement, Weekend CEO Chris Backus said the Vancouver-based recreational cannabis group’s partnership with True North allows it to “leverage” their specialized product upgrading process. Codebase Ventures Inc (CSE:CODE) (OTCMKTS:BKLLF) portfolio company World High Life Plc (NEX:LIFE) has tapped global mixed martial arts superstar Georges St-Pierre as the face of its Love Hemp brand.  St-Pierre, or GSP as he is known to fans, is a UFC world champion and Canada’s Athlete of the Year from 2008 to 2010. Co-Diagnostics Inc (NASDAQ:CODX) announced Tuesday that the GenomeWeb webinar scheduled to be delivered on February 5 will provide insight into the work on the company’s assay to detect the new strain of the deadly coronavirus. The webinar will also include a behind-the-scenes look at the collaborative development of an innovative multiplex test for infectious diseases in mosquito populations, the company said in a statement. Exactus Inc (OTCMKTS:EXDI) is advancing its business by striking up a supply and distribution pact with Hemptown USA. The agreement offers Exactus the chance to purchase and sell Hemptown’s raw cannabidiol materials like flower, isolates and distillates. Media Central Corporation Inc (CSE:FLYY) on Tuesday said digital audience growth at subsidiary NOW Magazine's nowtoronto.com grew by double digits in just one month. In addition to audience growth, NOW has seen significant shifts in other key audience and advertiser metrics, as measured by Google Analytics from December 31 to January 31, the company said in a statement. Pacific Empire Minerals Corp (CVE:PEMC), the prospect generator, unveiled assays from 2019 drilling at the Pinnacle project in British Columbia, which showed the potential for a porphyry system with a broad halo of gold. Four holes were sunk using the group's own drill reverse circulation (RC) rig in November and December last year. Australis Capital Inc (CSE:AUSA) (OTCMKTS:AUSAF), which operates and builds differentiated cannabis companies, has inked a non-binding letter of intent to acquire payment services provider Paytron LLC. Paytron will continue to operate as an independent sales organization while also becoming the payment branch for Cocoon Technology LLC, an Australis portfolio company that provides self-service technology to cannabis companies. The firm offers merchant services, including credit and debit card processing, secure gateway processing, point of sale hardware, card terminals and business loans. As part of the acquisition, the company announced that Marc Ruben will join the AUSA team as vice president of payments. TIMIA Capital Corporation (CVE:TCA) (OTCMKTS:TIMCF) has provided retailer-focused digital group Zmags with a US$3 million finance facility to expand its offering. TIMIA is a specialty finance company providing growth capital to tech firms in the fast-growing, software-as-a-service (SaaS) segment.  FSD Pharma Inc (CSE:HUGE) (NASDAQ:HUGE), the specialty biotech, revealed it has amended its deal with Solarvest Bioenergy Inc designed to accelerate progress on the latter's CBD research project. As reported in May last year, Solarvest (CVE:SVS), based in Vancouver, British Columbia, holds a platform capable of producing health products from algae. Dr. David Jin, the CEO of Avalon GloboCare Corp (NASDAQ:AVCO), the cell therapy group, will lead a session called “Cellular Therapy in the Asia Pacific Region” at the Transplantation & Cellular Therapy meetings in Orlando, Florida on February 20. The meetings are sponsored by the American Society of Transplantation and Cellular Therapy and the Center for International Blood and Marrow Transplant Research. Dr. Jin’s talk will address trends in cellular therapy hitting areas like CAR-T across Asia and the Pacific rim. It will take place from 1pm to 4pm on February 20 in Product Theatre Room 1 of the Exhibit Hall at the Orlando World Center Marriott in Orlando, Florida. At the close of last year, Avalon unveiled a strategic partnership with China (Nanjing) Cell Valley (CNCV) – one of the largest biotech zone initiatives in China. The aim of the new tie-up is to cultivate technological advances in the CellTech industry in China. Avalon specializes in CAR-T therapies, which involve genetically modifying T-cells, specifically manufactured for each individual patient, to activate the body’s immune system in order to recognize and destroy cancer cells. Asterion Cannabis Inc, the privately-owned Canadian medicinal cannabis company, said it is now officially listed on the Australian government's Department of Health and Office of Drug Control as a medicinal cannabis manufacturer and supplier. Imagination Park Technologies Inc. (CSE:IP) (OTCMKTS:IPNFF) has announced the resignation of Gerry Feldman as a director with effect from Tuesday, The group said its board plans to fill the vacated seat prior to the AGM in March. Alen Paul Silverrstieen commented: "We thank Gerry for his contributions as a Board of Director Member since last February ". Progressive Planet Solutions Inc (CVE:PLAN) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement, announced on December 4, 2019, which will see the issue of 2,705,000 flow-through shares at a purchase price of 7 cents each, plus 2,705,000 share purchase warrants at an exercise price of 7.5 cents for a six-month period, together with 2.01 million non-flow-through shares at a purchase price of 6 cents each with 2.01 million share purchase warrants at an exercise price of 7.5 cents for a six-month period, with 12 placees. Biocept, Inc. (NASDAQ:BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, said its president and CEO, Michael W. Nall will present a corporate overview at the 22nd Annual BIO CEO & Investor Conference on Monday, February 10, 2020, at 9:00am Eastern time (6:00am Pacific time) at the New York Marriott Marquis in New York City. The group said a live webcast of the conference presentation will be available on the company's website and a replay of the webcast will be available for 90 days. ir.biocept.com